|
gptkbp:instanceOf
|
biotechnology company
|
|
gptkbp:acquisition
|
gptkb:Astellas_Pharma
|
|
gptkbp:focus
|
oncology
|
|
gptkbp:founded
|
1991
|
|
gptkbp:founder
|
gptkb:Colin_Goddard
|
|
gptkbp:headquarters
|
gptkb:Long_Island,_New_York
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
OSI Pharmaceuticals
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:keyPeople
|
gptkb:Colin_Goddard
gptkb:Mitsuo_Satoh
gptkb:Masafumi_Nogimori
|
|
gptkbp:location
|
gptkb:United_States
|
|
gptkbp:notableEvent
|
Tarceva
|
|
gptkbp:products
|
gptkb:Atezolizumab
gptkb:Lorlatinib
gptkb:Nivolumab
gptkb:Sorafenib
gptkb:Brigatinib
gptkb:Zanubrutinib
gptkb:Copanlisib
gptkb:Melflufen
gptkb:Lapatinib
gptkb:Vemurafenib
gptkb:Osimertinib
gptkb:Alectinib
gptkb:Durvalumab
gptkb:Abecma
gptkb:Cobimetinib
gptkb:Idelalisib
gptkb:Dabrafenib
gptkb:Neratinib
gptkb:Dacomitinib
gptkb:Pembrolizumab
Crizotinib
Ipilimumab
Tremelimumab
Binimetinib
Trametinib
Olaratumab
Erlotinib
Gefitinib
Entrectinib
Polatuzumab vedotin
Rociletinib
Selinexor
Pazopanib
Duvelisib
Blinatumomab
Ibrutinib
Acalbrutinib
Axitinib
Brentuximab vedotin
Ciltacabtagene autoleucel
Inotuzumab ozogamicin
Mogamulizumab
Regorafenib
Selumetinib
Tazemetostat
Tivozanib
Venetoclax
|
|
gptkbp:subsidiary
|
gptkb:OSI_Oncology
|
|
gptkbp:type
|
public company
|
|
gptkbp:website
|
www.osip.com
|